Eye drop solution
Vietnam·Risk Class TBYT Loại B·Natamycin Ophthalmic Suspension USP 5%·INDIANA OPHTHALMICS LLP·Registered Oct 31, 2024- Analysis ID
- 240002513/PCBB-HCM
- Submission ID
- 000.00.19.H29-241029-0025
- Product Type
- Natamycin Ophthalmic Suspension USP 5%
- Manufacturer
- INDIANA OPHTHALMICS LLP
- Product Owner
- INDIANA OPHTHALMICS LLP
- Authorized Representative
- CÔNG TY TNHH DƯỢC PHẨM TRANG THIẾT BỊ Y TẾ SONG HIẾU
- Intended Use
- Supporting the treatment of fungal tarsal conjunctivitis, bacterial conjunctivitis and keratitis caused by sensitive bacteria, including Fusarium solani. Similar to other forms of bacterial keratitis, the initial and maintenance therapy should be determined by clinical diagnosis, and by culture and sensitivity testing of corneal scrapings, as well as by the corneal response to therapy. If possible, the in vitro activity of Natamycin against the pathogenic fungus should be determined. The effectiveness of Natamycin as a monotherapy in fungal endophthalmitis has not been established.
- Registration Date
- Oct 31, 2024
Companies providing products similar to "Eye drop solution"
Recently registered similar products
Access comprehensive regulatory information for Eye drop solution in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại B medical device is registered under number 240002513/PCBB-HCM and manufactured by INDIANA OPHTHALMICS LLP. The authorized representative in Vietnam is CÔNG TY TNHH DƯỢC PHẨM TRANG THIẾT BỊ Y TẾ SONG HIẾU.
This page provides complete technical specifications, regulatory compliance details, 5 companies making similar products including CÔNG TY CỔ PHẦN LIÊN DOANH CÔNG NGHỆ DƯỢC PHẨM VIỆT Ý, DCareme Co., Ltd., and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.